Shorter radiation + new drug: a new hope for advanced rectal cancer?
NCT ID NCT07448077
Summary
This study is testing a new treatment approach for people with locally advanced rectal cancer that has not spread to distant organs. It combines a shorter, more intense course of radiation with chemotherapy and a new immunotherapy drug called enlonstobart, given before surgery. The main goal is to see if this combination can completely eliminate the cancer before surgery and improve long-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EFFICACY AND SAFETY OF SHORT-COURSE RADIOTHERAPY IN TOTAL NEOADJUVANT THERAPY COMBINED WITH ENLONSTOBART FOR PMMR LOCALLY ADVANCED RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.